Keros Therapeutics Inc (KROS) — Defensive Interval Ratio
Keros Therapeutics Inc (KROS) has a Defensive Interval Ratio of 84 days as of September 2025. Defensive assets of $5.57 Million (cash $-, short-term investments $-, receivables $5.57 Million) cover 84 days of daily cash needs of $66.01K/day. Check KROS tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Keros Therapeutics Inc Defensive Interval Ratio (2019–2024)
This chart shows how Keros Therapeutics Inc's Defensive Interval Ratio has evolved across 6 annual periods from 2019 to 2024. As of September 2025, the ratio stands at 84 days, meaning defensive assets of $5.57 Million can fund 84 days of operations without new revenue. Also explore KROS net assets growth trend to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for Keros Therapeutics Inc (2019–2024)
The table below presents the year-by-year Defensive Interval Ratio for Keros Therapeutics Inc from 2019 to 2024, covering 6 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see Keros Therapeutics Inc market cap and net worth.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 59 days | $4.46 Million | $75.21K/day | $- | $- | ▲ +43 days |
| 2023 | 16 days | $1.09 Million | $66.78K/day | $- | $- | ▼ -2 days |
| 2022 | 19 days | $841.00K | $45.33K/day | $- | $- | ▼ -542 days |
| 2021 | 561 days | $18.20 Million | $32.45K/day | $- | $- | ▲ +550 days |
| 2020 | 11 days | $216.00K | $19.68K/day | $- | $- | ▼ -64 days |
| 2019 | 75 days | $922.00K | $12.29K/day | $- | $- | — |